Statements (13)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
stock ticker
|
| gptkbp:CEO |
gptkb:Adrian_Gottschalk
|
| gptkbp:country |
gptkb:United_States
|
| gptkbp:focusesOn |
epigenetic drug development
|
| gptkbp:foundedYear |
2015
|
| gptkbp:headquartersLocation |
gptkb:Cambridge,_Massachusetts
|
| https://www.w3.org/2000/01/rdf-schema#label |
FHTX
|
| gptkbp:industry |
gptkb:biotechnology
|
| gptkbp:listedOn |
gptkb:NASDAQ
|
| gptkbp:represents |
gptkb:Foghorn_Therapeutics_Inc.
|
| gptkbp:website |
https://www.foghorntx.com/
|
| gptkbp:bfsParent |
gptkb:Foghorn_Therapeutics
|
| gptkbp:bfsLayer |
7
|